This article intends to examine four analytical contexts, organized into the same number of general objectives. The first context: Explain the foundations of the regulatory systems of state intervention in the drug market. The second: Analyze some economic-social contexts of the drug market in Panama and its comparisons with Latin American countries. The third: Assess the measures related to the issue of medicines, officially adopted by the national government

in July 2022, as part of the results of the Single Dialogue Table for Panama; and the Fourth: Highlight the balance of the conditions required to favor changes in the development of public policies in access, prices and quality of the supply of medicines in Panama.

We highlight the methodological aspects with a broad comprehensive vision of the objective need for regulatory policies in the drug market, especially those existing controversies between the market fetishist neoliberalism approach and the perspective of the common welfare economy. It also analyzes the factors of state intervention in the drug market, particularly in the conditions of prices and incidence in wages, comparing the situation of Panama with important Latin American countries.

Finally, it is emphasized that in the regulations approved in July 2022 there are favorable purposes and evidence. In spite of this, the conditions of the validity times stand out, very short and not at all prudential, in order to structure corrective operations with lasting contexts, and thus establish scientific and integral planning mechanisms on a permanent basis.